Zymeworks Inc. (ZYME)

Mar 27, 2025

Ecor1 Capital’s Oleg Nodelman buys $1.23 million in Zymeworks stock By Investing.com - Investing.com Canada

Mar 27, 2025

Mar 26, 2025

Zymeworks to Engage Investors at Upcoming Conferences - TipRanks

Mar 26, 2025

Mar 26, 2025

Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire

Mar 26, 2025

Mar 26, 2025

Clinical-Stage Biotech Zymeworks Reveals New Pipeline Insights at Two Major Healthcare Conferences - StockTitan

Mar 26, 2025

Mar 25, 2025

Zymeworks to Present Promising Cancer Therapy Data at AACR Meeting - TipRanks

Mar 25, 2025

Mar 25, 2025

Zymeworks to Present Preclinical Data on T cell Engager and - GlobeNewswire

Mar 25, 2025

Mar 25, 2025

Game-Changing Cancer Drug Results: Zymeworks Reveals 6 Promising Treatments at AACR - StockTitan

Mar 25, 2025

Mar 25, 2025

Zymeworks Inc. (ZYME): Among Stocks Receiving the Most Insider Love in March - Insider Monkey

Mar 25, 2025

Mar 24, 2025

EcoR1 Capital, LLC Increases Stake in Zymeworks Inc - GuruFocus.com

Mar 24, 2025

Mar 24, 2025

Zymeworks Inc. sees $1.64 million stock purchase by EcoR1 Capital - Investing.com Philippines

Mar 24, 2025

Mar 21, 2025

EcoR1 Capital, LLC's Strategic Acquisition of Zymeworks Inc Shar - GuruFocus.com

Mar 21, 2025

Mar 20, 2025

Insiders Are Spending Big: 15 Stocks Leading in March - Insider Monkey

Mar 20, 2025

Mar 19, 2025

Zymeworks sees over $2.8 million in stock purchases by EcoR1 Capital - Investing.com Australia

Mar 19, 2025

Mar 16, 2025

Zymeworks Inc. (NYSE:ZYME) Receives $21.00 Consensus PT from Brokerages - Defense World

Mar 16, 2025

Mar 14, 2025

Q1 Earnings Estimate for Zymeworks Issued By Lifesci Capital - Defense World

Mar 14, 2025

Mar 13, 2025

EcoR1 capital acquires $13.1 million in Zymeworks stock By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 13, 2025

EcoR1 capital acquires $13.1 million in Zymeworks stock - Investing.com India

Mar 13, 2025

Mar 13, 2025

Equities Analysts Issue Forecasts for Zymeworks Q1 Earnings - Defense World

Mar 13, 2025

Mar 12, 2025

Zymeworks (ZYME) Soars 5.4%: Is Further Upside Left in the Stock? - Nasdaq

Mar 12, 2025

Mar 12, 2025

Zymeworks (NYSE:ZYME) Now Covered by Analysts at Lifesci Capital - Defense World

Mar 12, 2025

Mar 11, 2025

LifeSci Capital Initiates Coverage of Zymeworks (ZYME) with Outperform Recommendation - Nasdaq

Mar 11, 2025

Mar 11, 2025

Industry Analysts Just Upgraded Their Zymeworks Inc. (NASDAQ:ZYME) Revenue Forecasts By 13% - Simply Wall St

Mar 11, 2025

Mar 11, 2025

Zymeworks (NYSE:ZYME) Price Target Raised to $13.00 at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

Deep Dive Into Zymeworks Stock: Analyst Perspectives (4 Ratings) - Benzinga

Mar 10, 2025

Mar 10, 2025

Analysts Just Shipped A Captivating Upgrade To Their Zymeworks Inc. (NASDAQ:ZYME) Estimates - Yahoo Finance

Mar 10, 2025

Mar 09, 2025

Citigroup Boosts Zymeworks (NYSE:ZYME) Price Target to $19.00 - Defense World

Mar 09, 2025

Mar 06, 2025

Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251 - Benzinga India

Mar 06, 2025

Mar 06, 2025

Zymeworks Inc. (NYSE:ZYME) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 06, 2025

Mar 06, 2025

Zymeworks Inc (ZYME) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Insights - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

Zymeworks Inc (ZYME) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Insights By GuruFocus - Investing.com Canada

Mar 06, 2025

Mar 05, 2025

Zymeworks Reports 2024 Financial Results and Pipeline Progress - TipRanks

Mar 05, 2025

Mar 05, 2025

Zymeworks Achieves FDA Approval for Ziihera® - TipRanks

Mar 05, 2025

Mar 05, 2025

Zymeworks Inc. (ZYME) Reports Q4 Loss, Misses Revenue Estimates - MSN

Mar 05, 2025

Mar 05, 2025

Zymeworks Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025

Mar 05, 2025

Earnings call transcript: Zymeworks Q4 2024 sees modest revenue, stock dips - Investing.com UK

Mar 05, 2025

Mar 05, 2025

Zymeworks Q4 Net Loss Widens, Revenue Increases; Shares Fall After Hours -March 05, 2025 at 04:55 pm EST - Marketscreener.com

Mar 05, 2025

Mar 05, 2025

Zymeworks Inc Q4 2024 Earnings: EPS of -$0.31 and Revenue of $31 - GuruFocus.com

Mar 05, 2025

Mar 05, 2025

Zymeworks shares fall as Q4 earnings miss expectations By Investing.com - Investing.com Canada

Mar 05, 2025

Mar 05, 2025

Zymeworks shares fall as Q4 earnings miss expectations - Investing.com India

Mar 05, 2025

Mar 05, 2025

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 05, 2025

Mar 05, 2025

How Will Zymeworks' FDA Win for Ziihera Impact Its $122M Annual Loss? - StockTitan

Mar 05, 2025

Mar 05, 2025

Rhumbline Advisers Buys 15,920 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World

Mar 05, 2025

Mar 04, 2025

Zymeworks Inc (ZYME) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Zymeworks (ZYME) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 03, 2025

Feb 28, 2025

Zymeworks Inc.'s (NASDAQ:ZYME) Business Is Yet to Catch Up With Its Share Price - Simply Wall St

Feb 28, 2025

Feb 28, 2025

Zymeworks Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsZYME - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration - Wahanariau

Feb 27, 2025

Feb 26, 2025

Zymeworks Achieves $14 Million in Milestone Payment From GSK Partnership -February 26, 2025 at 09:06 am EST - Marketscreener.com

Feb 26, 2025